Company page

Annovis Bio, Inc.

Annovis Bio, Inc. (Ticker: ANVS) is a public company based in the United States with a market capitalization of approximately $74.4 million. The company focuses on developing therapies for neurodegenerative diseases. Annovis Bio is committed to advancing its research and improving patient outcomes in this critical area of healthcare.